Kimberly-Clark de Mexico SAB de CV (OTCMKTS:KCDMY – Get Free Report) posted its quarterly earnings data on Tuesday. The basic materials company reported $0.20 earnings per share for the quarter, meeting the consensus estimate of $0.20, Zacks reports. Kimberly-Clark de Mexico SAB de CV had a net margin of 13.92% and a return on equity of 164.99%. The firm had revenue of $830.35 million during the quarter, compared to analysts’ expectations of $839.55 million.
Kimberly-Clark de Mexico SAB de CV Price Performance
OTCMKTS:KCDMY traded down $0.02 during mid-day trading on Thursday, reaching $11.17. The stock had a trading volume of 3,663 shares, compared to its average volume of 49,651. The stock has a market capitalization of $6.87 billion, a P/E ratio of 15.96 and a beta of 0.67. The firm has a 50 day moving average price of $10.98 and a two-hundred day moving average price of $11.44. Kimberly-Clark de Mexico SAB de CV has a one year low of $8.25 and a one year high of $12.84. The company has a debt-to-equity ratio of 11.44, a quick ratio of 1.36 and a current ratio of 1.55.
Analyst Upgrades and Downgrades
Separately, HSBC downgraded shares of Kimberly-Clark de Mexico SAB de CV from a “buy” rating to a “hold” rating in a report on Wednesday, April 29th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.
Kimberly-Clark de Mexico SAB de CV Company Profile
Kimberly-Clark de México, SAB. de C.V. operates as one of the leading manufacturers of personal care and paper‐based products in Mexico. As a locally managed subsidiary of the global Kimberly-Clark Corporation, the company focuses on the production, marketing and distribution of consumer staples designed for everyday use, ranging from facial and bathroom tissue to diapers and feminine care items.
The company’s portfolio includes well-known brands such as Kleenex and Scott for tissue products, Huggies for baby care, Kotex for feminine hygiene and Depend for adult incontinence.
Recommended Stories
- Five stocks we like better than Kimberly-Clark de Mexico SAB de CV
- Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken
- Cementing the Sky: Why NVIDIA’s Bet on Nebius Matters
- Forging Profits: The Executive Order Sparking Aluminum
- Thematic Memory ETFs Give Investors a New Way to Play AI’s Hidden Bottleneck
Receive News & Ratings for Kimberly-Clark de Mexico SAB de CV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark de Mexico SAB de CV and related companies with MarketBeat.com's FREE daily email newsletter.
